APA (7th ed.) Citation

Hsiao, Y., Chiang, S., Wang, C., Chi, N., Yu, H., Hong, T., . . . Yu, S. (2024). Epigenomic biomarkers insights in PBMCs for prognostic assessment of ECMO-treated cardiogenic shock patients. Clinical Epigenetics, 16(1), 1. https://doi.org/10.1186/s13148-024-01751-6

Chicago Style (17th ed.) Citation

Hsiao, Yi-Jing, et al. "Epigenomic Biomarkers Insights in PBMCs for Prognostic Assessment of ECMO-treated Cardiogenic Shock Patients." Clinical Epigenetics 16, no. 1 (2024): 1. https://doi.org/10.1186/s13148-024-01751-6.

MLA (9th ed.) Citation

Hsiao, Yi-Jing, et al. "Epigenomic Biomarkers Insights in PBMCs for Prognostic Assessment of ECMO-treated Cardiogenic Shock Patients." Clinical Epigenetics, vol. 16, no. 1, 2024, p. 1, https://doi.org/10.1186/s13148-024-01751-6.